. . . . . . "Used in the treatment of acute or chronic schizophrenic reactions in hospitalized patients."@en . "Carphenazine"@en . . "withdrawn"@en . "Carphenazin"@en . . . . . . . "A yellow, powdered, phenothiazine antipsychotic agent used in the treatment of acute or chronic schizophrenia. The term \"phenothiazines\" is used to describe the largest of the five main classes of neuroleptic antipsychotic drugs. These drugs have antipsychotic and, often, antiemetic properties, although they may also cause severe side effects such as akathisia, tardive dyskinesia and extrapyramidal symptoms. Carphenazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis."@en . . "Carfenazine"@en . . . . "Carphenazine is an antipsychotic drug, used in hospitalized patients in the management of chronic schizophrenic psychoses."@en . . . . . . . " "@en . . . . . "Tislow, R.F., Bruce, W.F. and Page, J.A.; US. Patent 3,023,146; February 27,1962; assigned to American Home Products Corporation. Sherlock, M.H. and Sperber, N.; US. Patent 2,985,654; May 23, 1961; assigned to Schering Corporation."@en . . "2622-30-2"@en . "Humans and other mammals"@en . . . . . . .